Uniyal P, Kashyap V, Behl T, Parashar D, Rawat R
Cancers (Basel). 2025; 17(5).
PMID: 40075634
PMC: 11899378.
DOI: 10.3390/cancers17050785.
DeWitt J, Chinwuba J, Kellogg D
Genetics. 2023; 225(2).
PMID: 37531631
PMC: 10758756.
DOI: 10.1093/genetics/iyad144.
Kim M, Kim K
BMC Complement Med Ther. 2023; 23(1):238.
PMID: 37454069
PMC: 10349518.
DOI: 10.1186/s12906-023-04066-w.
Kim M, Kim J, Kim K
Biomimetics (Basel). 2022; 7(4).
PMID: 36278711
PMC: 9624328.
DOI: 10.3390/biomimetics7040154.
Kim M, Leem Y
J Exerc Nutrition Biochem. 2019; 23(3):13-21.
PMID: 31743979
PMC: 6823649.
DOI: 10.20463/jenb.2019.0018.
A prognostic index based on an eleven gene signature to predict systemic recurrences in colorectal cancer.
Kim S, Kim S, Kim C, Roh S, Ha Y, Lee J
Exp Mol Med. 2019; 51(10):1-12.
PMID: 31578316
PMC: 6802642.
DOI: 10.1038/s12276-019-0319-y.
From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers.
Saliani M, Jalal R, Ahmadian M
Cancer Biol Med. 2019; 16(3):435-461.
PMID: 31565476
PMC: 6743616.
DOI: 10.20892/j.issn.2095-3941.2018.0530.
Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells.
Zhang J, Sun Z, Han Y, Yao R, Yue L, Xu Y
Oncol Lett. 2017; 13(5):3817-3822.
PMID: 28529595
PMC: 5431740.
DOI: 10.3892/ol.2017.5868.
Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
Kim J, Weiss H, Evers B
Int J Oncol. 2017; 50(6):2200-2206.
PMID: 28498396
PMC: 5435327.
DOI: 10.3892/ijo.2017.3990.
H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair.
Ciocci M, Iorio E, Carotenuto F, Khashoggi H, Nanni F, Melino S
Oncotarget. 2016; 7(51):84338-84358.
PMID: 27741519
PMC: 5356665.
DOI: 10.18632/oncotarget.12609.
Anticolorectal cancer effects and pharmacokinetic application of 2, 2-Bis [4-(4-amino-3-hydroxyphenoxy) phenyl] adamantane.
Yang P, Wang J, Tsai T, Wang Y, Jan W, Cheng S
Int J Clin Exp Med. 2015; 8(9):14805-15.
PMID: 26628962
PMC: 4658851.
Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
Kim J, Li J, Song J, Lee E, Weiss H, Townsend Jr C
Oncotarget. 2015; 6(29):26960-70.
PMID: 26298774
PMC: 4694966.
DOI: 10.18632/oncotarget.4745.
Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation.
Yunn N, Koh A, Han S, Lim J, Park S, Lee J
Nucleic Acids Res. 2015; 43(16):7688-701.
PMID: 26245346
PMC: 4652772.
DOI: 10.1093/nar/gkv767.
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.
Engstrom W, Darbre P, Eriksson S, Gulliver L, Hultman T, Karamouzis M
Carcinogenesis. 2015; 36 Suppl 1:S38-60.
PMID: 26106143
PMC: 4565610.
DOI: 10.1093/carcin/bgv030.
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Goodson 3rd W, Lowe L, Carpenter D, Gilbertson M, Ali A, Lopez de Cerain Salsamendi A
Carcinogenesis. 2015; 36 Suppl 1:S254-96.
PMID: 26106142
PMC: 4480130.
DOI: 10.1093/carcin/bgv039.
The C. elegans NR4A nuclear receptor gene nhr-6 promotes cell cycle progression in the spermatheca lineage.
Praslicka B, Gissendanner C
Dev Dyn. 2014; 244(3):417-30.
PMID: 25529479
PMC: 4344872.
DOI: 10.1002/dvdy.24244.
BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications.
Oikonomou E, Koustas E, Goulielmaki M, Pintzas A
Oncotarget. 2014; 5(23):11752-77.
PMID: 25361007
PMC: 4322985.
DOI: 10.18632/oncotarget.2555.
Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.
Stjernstrom A, Karlsson C, Fernandez O, Soderkvist P, Karlsson M, Thunell L
Cancer Med. 2014; 3(2):337-48.
PMID: 24500884
PMC: 3987083.
DOI: 10.1002/cam4.191.
SPIN90 knockdown attenuates the formation and movement of endosomal vesicles in the early stages of epidermal growth factor receptor endocytosis.
Oh H, Kim H, Chung K, Hong N, Shin B, Park W
PLoS One. 2013; 8(12):e82610.
PMID: 24340049
PMC: 3858329.
DOI: 10.1371/journal.pone.0082610.
New susceptibility locus for obesity and dyslipidaemia on chromosome 3q22.3.
Alshahid M, Wakil S, Al-Najai M, Muiya N, Elhawari S, Gueco D
Hum Genomics. 2013; 7:15.
PMID: 23738802
PMC: 3681549.
DOI: 10.1186/1479-7364-7-15.